Mouse anti Cytokeratin 10 / Keratin K10

Mouse anti Cytokeratin 10 / Keratin K10, IgG1, Clone: RKSE60

Clone: RKSE60

Background: Cytokeratins are a subfamily of intermediate filament proteins and are characterized by a remarkable biochemical diversity, represented in Human epithelial tissues by at least 20 different polypeptides. They range in molecular weight between 40 kDa and 68 kDa and isoelectric pH between 4.9 – 7.8. The individual Human Cytokeratins are numbered 1 to 20. The various epithelia in the Human body usually express Cytokeratins which are not only characteristic of the type of epithelium, but also related to the degree of matuRation or differentiation within an epithelium. Cytokeratin subtype expression patterns are used to an increasing extent in the distinction of different types of epithelial malignancies. The Cytokeratin antibodies are not only of assistance in the differential diagnosis of tumors using immunohistochemistry on tissue sections, but are also a useful tool in cytopathology and flow cytometric assays.

Source: RKSE60 is a Mouse monoclonal IgG1 antibody derived by fusion of SP2/0 Mouse myeloma cells with spleen cells from a BALB/c Mouse immunized with Cytokeratins from the Human epidermis.

Specificity: RKSE60 reacts exclusively with Cytokeratin 10 which is present in Keratinizing stRatified epithelia and in differentiated areas of highly differentiated squamous cell carcinomas.

Formulation: Each vial contains 100 ul 1 mg/ml purified monoclonal antibody in PBS containing 0.09% sodium azide.

References: 1. Ramaekers, F. C., Puts, J. J., Moesker, O., Kant, A., Huysmans, A., Haag, D., Jap, P. H., Herman, C. J., and Vooijs, G. P. (1983). Antibodies to intermediate filament proteins in the immunohistochemical identifiCation of Human tumours: an overview, Histochem J 15, 691-713. 2. Puts, J. J., Moesker, O., Kenemans, P., Vooijs, G. P., and Ramaekers, F. C. (1985). Expression of Cytokeratins in early neoplastic epithelial lesions of the uterine cervix, Int J Gynecol Pathol 4, 300-13. 3. Broers, J. L., Carney, D. N., Klein Rot, M., Schaart, G., Lane, E. B., Vooijs, G. P., and Ramaekers, F. C. (1986). Intermediate filament proteins in classic and variant types of small cell lung carcinoma cell lines: a biochemical and immunochemical analysis using a panel of monoclonal and polyclonal antibodies, J Cell Sci 83, 37-60. 4. Ramaekers, F., Huysmans, A., Schaart, G., Moesker, O., and Vooijs, P. (1987). Tissue distribution of Keratin 7 as monitored by a monoclonal antibody, Exp Cell Res 170, 235-49. 5. Van Muijen, G. N., Warnaar, S. O., and Ponec, M. (1987). Differentiation-related changes of Cytokeratin expression in cultured Keratinocytes and in fetal, newborn, and adult epidermis, Exp Cell Res 171, 331-45. 6. Bijman, J.T., Wagener, D.J.T., van Rennes, H., Wessels, J.M.C., Ramaekers, F.C.S. and van den Broek, P. (1987). Modulation of placental alkaline phosphatase activity and Cytokeratins in Human HN-1 cells by butyRate, retinoic acid, Catecholamines and histamine, Br. J. Cancer 56, 127-32. 7. Van Erp, P.E.J., Rijzewijk, J.J., Boezeman, J.B.M., Leenders, J., de Mare, S., Schalkwijk, J., van de Kerkhof, P.C.M., Ramaekers, F.C.S. and Bauer, F.W. (1989). Flow Cytometric analysis of epidermal subpopulations from normal and psoriatic skin using monoclonal antibodies anti intermediate filaments, Am J Pathol 135, 865-70. 8. Ramaekers, F., van Niekerk, C., Poels, L., Schaafsma, E., Huijsmans, A., Robben, H., Schaart, G., and Vooijs, P. (1990). Use of monoclonal antibodies to Keratin 7 in the differential diagnosis of adenocarcinomas, Am J Pathol 136, 641-55. 9. Schaafsma, H. E., Ramaekers, F. C., van Muijen, G. N., Lane, E. B., Leigh, I. M., Robben, H., Huijsmans, A., Ooms, E. C., and Ruiter, D. J. (1990). Distribution of Cytokeratin polypeptides in Human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression, Am J Pathol 136, 329-43. 10. Smedts, F., Ramaekers, F., Robben, H., Pruszczynski, M., van Muijen, G., Lane, B., Leigh, I., and Vooijs, P. (1990). Changing patterns of Keratin expression during progression of cervical intraepithelial neoplasia, Am J Pathol 136, 657-68. 11. Franssen, M.E.J., Boezeman, J.B.M., van de Kerkhof, P.C.M. and van Erp, P.E.J. (2003). Monitoring hyperproliferative disorders in Human skin: flow cytometry of changing Cytokeratin expression, Cytometry Part B (Clinical Cytometry) 57B, 32-39.

UniProt: P13645

Caution: This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving humans or animals. This product contains sodium azide. To prevent formation of toxic vapors, do not mix with strong acidic solutions. To prevent formation of potentially explosive metallic azides in metal plumbing, always wash into drain with copious quantities of water.This datasheet is as accurate as reasonably achievable, but Nordic-MUbio accepts no liability for any inaccuracies or omissions in this information.

• Artikelnummer: NORMUB0319P
• Hersteller: Nordic-MUbio
• Hersteller Artikelnummer: MUB0319P
• Verpackungseinheit: 0,1 mg
• Mengeneinheit: STK
• Reaktivität: Human, Mouse (Murine), Rat (Rattus), Pig (Porcine), Dog (Canine), Zebrafish
• Klonalität: Monoclonal
• Methode: Immunohistochemistry (frozen), Western Blotting, Flow Cytometry, Immunocytochemistry
• Isotyp: IgG1
• Wirt: Mouse
• Konjugat: Unconjugated